3.7:

Bioequivalence: Overview

JoVE 핵심
Pharmacology
JoVE 비디오를 활용하시려면 도서관을 통한 기관 구독이 필요합니다.  전체 비디오를 보시려면 로그인하거나 무료 트라이얼을 시작하세요.
JoVE 핵심 Pharmacology
Bioequivalence: Overview

600 Views

01:16 min

September 22, 2023

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed, they yield the same clinical effect and safety profile.

A key determinant of clinical effectiveness is that the peak concentration of the drug, and the time taken to achieve this peak concentration, must fall within an acceptable range. However, there can be variations in the bioavailability of a drug's dosage form. These discrepancies might occur between different manufacturers or even among different batches from the same manufacturer. The reason behind this is often inadequate control over the drug's physical properties during its formulation and manufacturing. This lack of control can affect how the drug disintegrates and dissolves, impacting its bioavailability. Finally, for a generic drug to gain approval, its bioequivalence profile must align closely with that of the reference product.